Initiator Pharma A/S Working Capital to Net Assets Ratio
Initiator Pharma A/S working capital to net assets ratio. Initiator Pharma A/S (INIT) has a Working Capital to Net Assets ratio of 106.5% as of September 2025. Working capital of Skr34.59 Million (current assets of Skr36.82 Million minus current liabilities of Skr2.23 Million) is measured against net assets of Skr32.47 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Initiator Pharma A/S's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Initiator Pharma A/S (2016–2024)
Working capital to net assets ratio of Initiator Pharma A/S from 2016 to 2024. This chart shows how Initiator Pharma A/S's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at 106.5%, reflecting working capital of Skr34.59 Million against net assets of Skr32.47 Million SEK. See INIT days of operational coverage to measure how many days the company can operate on defensive assets alone.
Initiator Pharma A/S Working Capital to Net Assets Ratio by Year (2016–2024)
Initiator Pharma A/S working capital to net assets ratio by year from 2016 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Initiator Pharma A/S from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Initiator Pharma A/S's balance sheet.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 99.9% | Skr14.77 Million | Skr14.78 Million | Skr15.28 Million | Skr510.00K | ▼ -138.3 pp |
| 2023 | 238.1% | Skr26.58 Million | Skr11.16 Million | Skr29.77 Million | Skr3.19 Million | ▲ +101.2 pp |
| 2022 | 136.9% | Skr46.58 Million | Skr34.02 Million | Skr48.33 Million | Skr1.75 Million | ▼ -1.1 pp |
| 2021 | 138.0% | Skr48.28 Million | Skr34.99 Million | Skr53.70 Million | Skr5.42 Million | ▲ +38.1 pp |
| 2020 | 99.9% | Skr14.40 Million | Skr14.41 Million | Skr15.59 Million | Skr1.19 Million | ▲ +0.3 pp |
| 2019 | 99.6% | Skr9.87 Million | Skr9.91 Million | Skr11.40 Million | Skr1.53 Million | ▲ +0.4 pp |
| 2018 | 99.3% | Skr16.45 Million | Skr16.57 Million | Skr17.20 Million | Skr758.00K | ▲ +2.8 pp |
| 2017 | 96.4% | Skr5.75 Million | Skr5.96 Million | Skr9.09 Million | Skr3.33 Million | ▼ -48.0 pp |
| 2016 | 144.5% | Skr-536.00K | Skr-371.00K | Skr398.00K | Skr934.00K | — |